Aeglea BioTherapeutics Inc. Stock Price (AGLE)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

What You Need to Know About Investing in Healthcare AISat, 23 Mar 2019 11:00:07 UTC via ETF Trends
HCP: Should You Buy This 4.8%-Yielding Healthcare REIT?Fri, 22 Mar 2019 09:18:13 UTC via Seeking Alpha
Prothena (PRTA) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 15:13:57 UTC via Seeking Alpha
Mesoblast (MESO) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 15:12:49 UTC via Seeking Alpha
VBI Vaccines (VBIV) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:32:49 UTC via Seeking Alpha
Synlogic (SYBX) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:32:07 UTC via Seeking Alpha
BioTime (BTX) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:31:41 UTC via Seeking Alpha
AcelRx Pharmaceuticals (ACRX) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:31:11 UTC via Seeking Alpha
Motus GI Holdings (MOTS) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:30:39 UTC via Seeking Alpha
Sorrento Therapeutics (SRNE) Presents At Oppenheimer 29th Annual Healthcare Conference - SlideshowThu, 21 Mar 2019 14:29:41 UTC via Seeking Alpha

Aeglea BioTherapeutics Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AGLE

You don't have any alerts set for IEX:AGLE.

About Aeglea BioTherapeutics Inc.

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

CEOAnthony G. Quinn IndustryBiotechnology SectorHealthcare Websitehttps://www.aegleabio.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time AGLE to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.